These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1350771)

  • 41. Urinary Markers of Tubular Injury in Early Diabetic Nephropathy.
    Fiseha T; Tamir Z
    Int J Nephrol; 2016; 2016():4647685. PubMed ID: 27293888
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [N-acetyl-beta-D-glucosaminidase].
    Sugita O
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():307-12. PubMed ID: 9513435
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of control of blood glucose on urinary excretion of N-acetyl-beta-D-glucosaminidase in elderly type 2 diabetes mellitus.
    Oba K; Igari Y; Matsumura N; Watanabe K; Inuzuka Y; Ajiro Y; Okazaki K; Sato S; Suzuki T; Nakano H; Metori S
    J Nippon Med Sch; 2000 Apr; 67(2):143-5. PubMed ID: 10754606
    [No Abstract]   [Full Text] [Related]  

  • 44. [Diabetic nephropathy--predictive methods].
    Isogai S; Inokuchi T; Kameyama M
    Nihon Rinsho; 1997 Oct; 55 Suppl():802-6. PubMed ID: 9392200
    [No Abstract]   [Full Text] [Related]  

  • 45. Evaluation of N-acetyl-β-D-glucosaminidase as a prognostic marker for diabetic nephropathy in type 2 diabetics: systematic review and meta-analysis.
    Dos Santos Bitencourt A; Vargas Filho RL; da Silveira Prestes G; Rodrigues Uggioni ML; Marçal F; Colonetti T; da Rosa MI
    Int Urol Nephrol; 2024 May; 56(5):1651-1661. PubMed ID: 37898960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic significance of urinary enzymes in nephrology.
    Turecky L; Uhlikova E
    Bratisl Lek Listy; 2003; 104(1):27-31. PubMed ID: 12830993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary protein patterns in diabetic nephropathy.
    Weber MH; Rothkegel S; Verwiebe R; Tewes C; Scheler F
    Contrib Nephrol; 1989; 73():30-42; discussion 42-4. PubMed ID: 2689096
    [No Abstract]   [Full Text] [Related]  

  • 48. [Diabetic nephropathy--progress in its preclinical and clinical studies].
    Kikkawa R; Koya D; Haneda M
    Nihon Naika Gakkai Zasshi; 2003 Sep; 92(9):1650-61. PubMed ID: 14560599
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].
    Minakami H
    Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity.
    Price RG
    Clin Nephrol; 1992; 38 Suppl 1():S14-9. PubMed ID: 1295704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Urinary N-acetyl-beta-D-glucosaminidase (NAG) in patients with diabetes mellitus].
    Oba K; Nakano H; Hirai M; Sato S
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():400-6. PubMed ID: 9513451
    [No Abstract]   [Full Text] [Related]  

  • 52. [Urinary N-acetyl-beta-D-glucosaminidase (NAG) in patients with diabetes mellitus].
    Suzuki T; Igari Y; Oba K
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():586-91. PubMed ID: 12355814
    [No Abstract]   [Full Text] [Related]  

  • 53. [N-acetyl-beta-D-glucosaminidase].
    Furuhata N; Shiba K; Nara N
    Nihon Rinsho; 1995 May; 53(5):1267-76. PubMed ID: 7602790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 3.